Stock Taper
Translational Development Acquisition Corp., founded in 2022 and headquartered in New York, New York, currently conducts no significant business operations. Its primary goal is to complete a business combination, such as a merger, amalgamation, share exchange, asset acquisition, share purchase, or reorganization, with one or more companies.

Overall rating: B
| PEER | PRICE | |
|---|---|---|
FACT | $10.69 | COMPARE |
SZZL | $10.45 | COMPARE |
MACI | $10.99 | COMPARE |
CEPO | $10.77 | COMPARE |
NTWO | $11.07 | COMPARE |
HCMA | $10.29 | COMPARE |